Showing results (3951-3960 of 5,132) with videos related to
Sort By:
Pageof 514
Maturitas|October 13, 2006
Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized womenToshiyuki Yasui, Hirokazu Uemura, Junko Tomita, et al.Maturitas|June 26, 2007
Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tiboloneWenpei Bai, Hans-Heinrich Henneicke-von Zepelin, Shuyu Wang, et al.Maturitas|September 16, 2006
Clinical aspects of obesity in the gynecological endocrinologicaly practiceAndrzej Milewicz, Diana JedrzejukMaturitas|June 15, 2007
Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal womenFadoua Allali, Houda Maaroufi, Siham El Aichaoui, et al.Maturitas|February 10, 2007
Hormonal therapy is associated with a lower prevalence of breast arterial calcification on mammographyPeter F Schnatz, Michelle A Rotter, Stephanie Hadley, et al.Maturitas|February 13, 2007
Life prevalence and determinants of hormone replacement therapy in women living in Porto, PortugalRaquel Lucas, Henrique BarrosMaturitas|May 29, 2007
Premenopausal factors influencing premature ovarian failure and early menopauseSoung Hoon Chang, Chung-Sik Kim, Kun-Sei Lee, et al.Maturitas|January 30, 2007
Dietary daidzein and puerarin do not affect pituitary LH expression but exert uterotropic effects in ovariectomized ratsDominik Rachoń, Tina Vortherms, Dana Seidlova-Wuttke, et al.Maturitas|December 1, 2006
Body mass index and gynecological factors as determinants of bone mass in healthy Moroccan womenAbdellah El Maghraoui, Ahmed Anas Guerboub, Aziza Mounach, et al.Maturitas|May 23, 2006
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulationA L Eilertsen, E Qvigstad, T O Andersen, et al.Pageof 514